Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment.
Reha-Baris IncesuSimone MorraLukas ScheipnerAndrea BaudoLetizia Maria Ippolita JannelloMario de AngelisCarolin SiechAnis AssadZhe TianFred SaadShahrokh F ShariatFelix K H ChunAlberto BrigantiOttavio de CobelliLuca CarmignaniSascha AhyaiNicola LongoDerya TilkiMarkus GraefenPierre I KarakiewiczPublished in: Journal of the National Comprehensive Cancer Network : JNCCN (2024)
Contemporary community-based patients with ccmRCC receiving active treatment clearly exhibited better survival than their historical counterparts, when examined as one group, as well as when examined as separate subgroups according to treatment type. Treatment advancements of phase III trials seem to be applied appropriately outside of centers of excellence.